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a  b  s  t  r  a  c  t
In Latin America, the disease burden of shigellosis is found to coexist with the rapid and ram-
pant  spread of resistance to commonly used antibiotics. The molecular basis of antibiotic
resistance lies within genetic elements such as plasmids, transposons, integrons, genomic
islands, etc., which are found in the bacterial genome. Integrons are known to acquire,
exchange, and express genes within gene cassettes and it is hypothesized that they play a
signiﬁcant role in the transmission of multidrug resistance genes in several Gram-negative
bacteria including Shigella. A few studies have described antibiotic resistance genes and
integrons among multidrug resistant Shigella isolates found in Latin America. For example,
in  Brazil, Bolivia, Chile, Costa Rica and Peru, class 1 and class 2 integrons have been detected
among multidrug resistant strains of Shigella; this phenomenon is more  frequently observed
in  S. ﬂexneri isolates that are resistant to trimethoprim, sulfamethoxazole, streptomycin,
ampicillin, chloramphenicol, and tetracycline. The gene cassette sul2, which is frequently
detected in Shigella strains resistant to the sulfonamides, suggests that the sulfonamide-
resistant phenotype can be explained by the presence of the sul2 genes independent of the
integron class detected. It is to be noted that sul3 was negative in all isolates analyzed in
these studies.
The high frequency of sulfonamide (as encoded by sul2) and trimethoprim resistance is
likely to be a result of the recurrent use of trimethoprim sulfamethoxazole as a popular
regimen for the treatment of shigellosis. The observed resistance proﬁles of Shigella strains
conﬁrm that ampicillin and trimethoprim-sulfamethoxazole are ineffective as therapeutic
options. In-depth information regarding antibiotic resistance mechanism in this pathogen
is  needed in order to develop suitable intervention strategies. There is a pressing need for
regional and local antimicrobial resistance proﬁling of Shigella to be included as a part of the
public health strategy.© 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This isan  open access arti
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ntroduction
higellae are global in terms of their prevalence and
istribution1 and shigellosis, which represents a signif-
cant cause of morbidity and mortality in developing
ountries, is still observed to be present in the industrialized
ations.1–3
The disease process of shigellosis can be accurately
ummed up as an invasive infection of the human colon that
ncompasses a wide spectrum of clinical manifestations ran-
ing from short-lasting watery diarrhea to acute inﬂammatory
owel disease that can cause fever, tenesmus as well as neu-
ologic symptoms.4,5
On the basis of biochemical and serological character-
stics, shigellae can be classiﬁed into four species: Shigella
ysenteriae,6 S. ﬂexneri,7 S. sonnei 8 and S. boydii.9 The ﬁrst three
pecies include multiple serotypes. While S. dysenteriae and
. ﬂexneri are the most commonly found species in developing
ountries, S. sonnei is responsible for most of the cases reported
n industrialized nations.1,4
Prevalence of Shigella is predominantly observed in regions
hat have poor hygienic and environmental conditions as is
ommon in developing countries. In industrialized nations,
revalence is found to be associated with groups or institu-
ions such as day-care centers.2,5,9
The infective dose of Shigella is reportedly as low as
0–100 bacterial cells. Transmission occurs from person to
erson through the fecal and oral pathway, and also by
onsumption of contaminated food or water.1,5 After an incu-
ation period of 1–4 days, patients typically present with
iarrhea, i.e., liquid stools that contain visible blood either
ith or without mucus.1 Severe, acute complications of
higellosis may include acute hypoglycemia, seizures, toxic
egacolon, hemolytic uremic syndrome, intestinal perfo-
ation, peritonitis, septicemia, etc., and can result in high
ortality rates especially among infants and malnourished
hildren.4,5
Shigellosis is endemic to most developing countries and
s responsible for nearly 165 million cases and more  than a
illion deaths annually. In the developing world, Shigella is
ssociated with a high burden of illness particularly among
hildren under ﬁve years of age, who  present with the major-
ty of cases (70%) and deaths (60%).1,10,11 This pathogen is also
requently associated with epidemic outbreaks that are asso-
iated with high morbidity and mortality.1
ethodology
he literature search for this review article included the
ollowing databases: SciELO (Scientiﬁc Electronic Library
n Line), Science Direct, OVID, Clinical Key, EBSCOhost,
ubMed (National Library of Medicine); LILACS (Latin Amer-
can and Caribbean Center on Health Sciences Information)
or peer-reviewed literature, and Google. The search terms
sed in English and Spanish were Shigella, antibiotic resis-
ance, resistencia a antibióticos, integron, Latin America and
mérica Latina.o l o g y 4 7 (2 0 1 6) 800–806 801
Emergence  of  multi  drug  resistance  in  Shigella
isolates  of  Latin  America
In Latin America, as in the rest of the world, the burden
of shigellosis has been greatly increased by the emergence
of microbial resistance toward antibiotics commonly used
for therapy; this usually results in failure of treatment
regimen.12–14 Therefore, early and appropriate antibiotic ther-
apy is crucial for reducing the duration of symptoms as
well as for preventing the development of life-threatening
complications.1 Additionally, antibiotics also greatly reduce
the excretion of the pathogen in stools which in turn reduces
the spread of bacteria into the environment.13
Antibiotic resistant Shigella was initially noticed in 1940 in
Japan when a serious outbreak of dysentery caused by S. dysen-
teriae was found to respond with decreasing effectiveness to
sulfonamides, the principal antibacterial treatment available
at the time. When antibiotics such as streptomycin, tetracy-
cline, and chloramphenicol became available in that country,
it was found that their efﬁcacy was temporary as resistant
strains were observed to develop soon after the drugs came
into the clinical use.15,16 Along similar lines, studies in Mexico
have described resistance of the species toward tetracycline
and chloramphenicol17 and, in 1977, Shigellae strains resistant
to ampicillin were isolated from similar epidemics in Mexico
and Central America.18,19 A few years later, an ampicillin resis-
tant phenotype of Shigella was detected in Asian and African
countries.20
Some reports in literature have documented an increased
resistance to antibiotics such as gentamicin trimethoprim-
sulfamethoxazole and -lactams in Latin American
countries.5,12,21–24 In 2008, the ﬁrst isolate of Shigella har-
boring the CMY-2 AmpC-lactamase enzyme was reported
in Argentina.22 This type of class C-lactamase is a clini-
cally relevant cephalosporinase known to be produced by
several Enterobacteriaceae strains; it is also known to medi-
ate resistance to antibacterial agents such as cephalothin,
cefazolin, cefoxitin, most derivatives of penicillin and
-lactam/-lactamase inhibitor combinations.25
The rapid emergence and propagation of resistance
has shifted the recommended treatment modalities to
ciproﬂoxacin and azithromycin.1 Ciproﬂoxacin, a ﬂuoro-
quinolone antibiotic formerly used as a backup drug, is now
the drug of choice for all patients that present with bloody diar-
rhea irrespective of their age. Alarmingly, ﬂuoroquinolone-
resistant Shigella sp. is an emerging phenotype around the
world including Latin America.12,13,24 Recently, a multistate
cluster of Shigella sonnei that had an uncommon pulsed-ﬁeld
gel electrophoresis proﬁle and was resistant to ciproﬂoxacin
was detected in the U.S. by the Centers of Disease Control
and Prevention (CDC)-National Antimicrobial Resistance Mon-
itoring System (NARMS).26 According to CDC-NARMS, 109 out
of the 126 (87%) Shigella isolates that were tested were found
to be non susceptible to ciproﬂoxacin. Ciproﬂoxacin-resistant
Shigella isolates were obtained from patients who  had trav-
eled to the Dominican Republic (one of ﬁve isolates tested) and
India (one of one isolate tested), and also among non-travelers
(four of seven isolates tested).26
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ReLAVRA (Latin American Network for the Surveillance of
Antimicrobial Resistance), a regional surveillance system sup-
ported by PAHO, has reported that S. ﬂexneri presents with
an elevated ciproﬂoxacin resistant rates as compared to S.
sonnei with a general upward trend observed in resistance
over time in Argentina, Bolivia, Chile, Dominican Republic
and Venezuela.27 Additionally, the appearance of quinolone-
resistance was also reported in 5% of the Shigella isolates
analyzed in Peru.24
Azithromycin is also considered as an alternative for
the treatment of shigellosis. However, its use is currently
handicapped by the limited data available with respect to
efﬁcacy, high cost and formulation.1 It is to be noted how-
ever that some studies regarding azithromycin have already
reported Shigella spp. as presenting with a decreased level
of susceptibility to the drug.28,29 Cases of Shigella isolates
with increased minimum inhibitory concentrations (MICs) for
azithromycin have already been documented in India and the
Netherlands.28,29
The ﬁrst report of Shigella that exhibited an increased MIC
to azithromycin was among pediatric patients in the Peru-
vian Amazon.30 In the above mentioned study, a total of
403 Shigella isolates were analyzed and results were found to
reveal an increased level of resistance toward trimethoprim-
sulfamethoxazole, ampicillin, erythromycin, and a decreased
level of susceptibility to ceftriaxone, azithromycin, nalidixic
acid, and ciproﬂoxacin.30
Another population cohort where this phenomenon was
initially identiﬁed was in the United States among men  who
had sex with men  (MSM).31 Since 1970 this route of infection
has been recognized as an important epidemiological compo-
nent of Shigellosis transmittance especially in high-income
nations. More  recently, it has been identiﬁed as an impor-
tant route for intercontinental spread of Shigella in MSM and
included disease cases from 29 countries collected between
1995 and 2014.32 In the above mentioned study, more  than 300
whole-genome Shigella isolates were analyzed and data thus
obtained revealed the presence of antibiotic resistance genes
in the MSM-outbreak associated lineage which suggested that
the ancestral strain of the lineage was multidrug resistant
prior to its introduction into the MSM  population.32,33 The
results of this study conﬁrmed that shigellosis is an impor-
tant emerging sexually transmitted infection among MSM and
it is already showing potential for global spread as well as for
resistance to commonly available antibiotics.
To date, the aforementioned report from Peru is the only
observation in all of Latin America for the presence of a
resistant phenotype of Shigella that exhibits a decreased sus-
ceptibility to azithromycin and ciproﬂoxacin, but such reports
can increase in frequency as more  intense research into
Shigella is undertaken and completed in other Latin American
countries.
Integrons:  molecular  mechanisms  behind
antibiotic  resistanceUnderstanding the changing resistance patterns of Shigella
spp. is important in terms of standardizing the appropri-
ate treatment. As early as 1959–1960, it was found that b i o l o g y 4 7 (2 0 1 6) 800–806
multiple antibiotic resistance characteristics present in
certain Shigella strains could be transferred to other Entero-
bacteriaceae simply by mixing liquid cultures of resistant and
sensitive bacteria and plating on solid medium containing
the appropriate antibiotics as selective agents.16,34 In 1976,
the R-plasmid associated with ampicillin resistance in Shigella
dysenteriae type 1 was characterized from a strain that was iso-
lated in a geographically widespread dysentery epidemic in
Mexico, Central America and Bangladesh.19 Since then, the
number of different studies that have described isolates of
“transferable drug resistance” has rapidly increased especially
when multidrug resistant strains were studied in differ-
ent countries indicating that the resistance determinants,
called R plasmids, often reﬂected the geography of antibiotic
usage.16,18
Antibiotic resistance determinants in bacteria are a con-
sequence of antimicrobial use and abuse. In terms of origin
and sources of the antibiotic resistance, a broader view
must include resistance genes of pathogenic as well as non-
pathogenic bacteria so as to encompass the full pan-microbial
genome or the resistome.35
In case of Shigella, similar to several other enteropathogens,
the molecular basis of antibiotic resistance resides in a small
part of the resistome within mobile genetic elements such
as the R plasmids, transposons, integrons, and genomic
islands.36
Although integrons were ﬁrst described only in 1989,30
bioinformatics based-analysis of sequenced bacterial
genomes clearly demonstrates that integrons or integrase
genes are very common in bacterial populations and are
known to sometimes occur with frequencies as high as
10–17%.37
These molecular platforms, ﬁrst discovered in clinical con-
texts, can be classiﬁed as class 1, class 2, and class 3 integrons.
Integrons have been proliﬁcally studied and analyzed as a
model system in order to arrive at a formal deﬁnition for
the structure of these genetic elements.38 Integrons are well
known as naturally occurring genetic elements that are capa-
ble of acquiring, exchanging and expressing genes within
gene cassettes.37 Structurally, they are composed of three key
elements: a tyrosine recombinase gene or integrase (intI), a
recombination site (attI) and a promoter site (Pc).36,30 All inte-
grons analyzed till today are composed of an intI gene that
encodes for an integrase enzyme. This enzyme which belongs
to the tyrosine recombinase family can recombine discrete
units of circularized DNA that are also known as genetic
cassettes.36,39 The other crucial integron component is the
primary recombination site (attI). A wide variety of genetic
cassettes that confer resistance to antibiotics can be found
in this speciﬁc region.36 Lastly, the third important compo-
nent of an integron is a strong promoter (Pc, Pant) that is
capable of directing transcription of the captured genes or
genetic cassettes.40 Genetic cassettes are small mobile units
composed of a coding sequence and a recombination site,
attC. Integrons exchange gene cassettes through integrase cat-
alyzed site speciﬁc recombination either between an attI and
attC sites or between two attC sites both of which lead to exci-
sion of the gene cassette.36,39
Each class of integron is uniquely different in terms of
the sequence of the integrase gene it encodes.37 While both
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lass 1 and class 2 integrons are known to contain antibi-
tic resistant gene cassettes, class 1 is the best example that
emonstrates evolution as driven by natural selection; this
s so because class1 integrons have been observed and char-
cterized from a variety of different locations, from different
lasmids and transposons, and their appearance is coincident
ith the widespread use of antibiotics.36,39
Integrons and gene cassettes are hypothesized to play a
rucial role in the mechanism that is responsible for trans-
ission of multidrug resistant genes in several Gram-negative
acteria.36,41,42 In Shigella, the dissemination of resistance-
nducing genes is mostly facilitated by the ability of the
acteria to acquire transposons or plasmids that may con-
ain integrons, especially class 1 and class 2 integrons,
hat are known to have a high density of resistance gene
assettes.36,42
The distribution of integrons varies according to the species
nd the resistant phenotype. S. sonnei and S. boydii strains
ontain a single class 2 integron whereas S. ﬂexneri and S.
ysenteriae strains are known to carry a class 1 integron, either
lone or associated with a class 2 integron.36,43,44
etection  of  integrons  and  genetic  cassettes  in
higella  isolates  from  Latin  America
n Latin America, the public information available regarding
higella is sufﬁcient for the emergence of multidrug resistant
arieties to be classiﬁed as a major public health problem.
ublished literature regarding phenotypic methodology based
ntibiotic resistance proﬁling of this pathogen clearly estab-
ishes a high prevalence of multidrug resistant Shigella among
atin American countries; however, the information regarding
olecular mechanisms responsible for antibiotic resistance in
his pathogen is very limited.
The INTEGRALL database (www.integrall.bio.ua.pt) has
 substantial amount of information regarding classes or
amilies of integrons isolated from other South Ameri-
an pathogens. This web-based platform, which has been
esigned for the purpose of organizing all data available for
hese genetic structures, is very useful tool for compiling
nformation on integrons.45 Till date, the INTEGRALL database
ontains more  than 7664 entries, including sequences of
509 integrase genes and 8559 gene cassettes, isolated from
44 genera and 323 species of bacteria. Of these available
equences, only 53 belong to Shigella and, unfortunately, there
re no studies regarding integrases and gene cassette arrays
rom isolates belonging to Latin America. Other South Amer-
can pathogens that have been described are: Acinetobacter,
lebsiella pneumoniae, Citrobacter freundii, Escherichia coli, Pseu-
omonas aeruginosa,  Pseudomonas putida and Salmonella spp.;
hese include several novel gene cassette arrays located in
nusual class 1 integrons.
Reports regarding the identiﬁcation and characterization
f these molecular structures in Shigella are scarce. In Brazil,
olivia, Chile, Costa Rica and Peru class 1 and class 2 integrons
ave been detected among multidrug resistant Shigella iso-
ates; such integrons are frequently associated with resistance
f Shigella to trimethoprim, sulfamethoxazole, streptomycin,
mpicillin, chloramphenicol, and tetracycline.24,46–49 Studieso l o g y 4 7 (2 0 1 6) 800–806 803
from Chile, Costa Rica and Peru showed that class 1 and
class 2 integrases are commonly found among S. ﬂexneri
isolates.24,46–48
In a study conducted in Brazil, Peirano et al.42 reported
the presence of class 1 integrons in a single isolate of S.
ﬂexneri and S. sonnei,  whereas class 2 integrons were report-
edly found in 56 of the 62 (90.3%) strains that were analyzed [S.
ﬂexneri (n = 43), S. sonnei (n = 13)]. Curiously, an isolate carrying
a class 1 integron was also found to carry an additional class
2 integron. Another study, also conducted in Brazil, reported
a higher frequency of intI-1 (92%, 23 out of 25 isolates) and
intI-2 (100% of 25 isolates) in S. sonnei isolates.43 In this study,
92% of the strains were found to be positive for two inte-
grons and all the strains that exhibited resistance toward two
or more  tested antibiotics revealed the presence of at least
one of the integrons. The detection rate of intI-2 in Shigella
(100%) was substantially higher than that reported for Costa
Rica 47 whereas; class 1 integrase (intI-1) was detected in all
of the 30 Shigella isolates analyzed [S. ﬂexneri (n = 25), S. son-
nei (n = 5)], whereas class 2 integrase was detected in 27 of the
30 isolates (90%). In the case of Bolivia, a study conducted on
Shigella spp. by Rodas et al.49 reported that the class 1 inte-
grase was present in 20 out of 45 isolates (44%) analyzed,
whereas class 2 integrase was found in 31 out of the 45 (69%)
strains.
In Peru, Lluque et al.,24 reported the presence of class 1 and
class 2 integrases in similar frequencies in case of S. ﬂexneri
(n = 42, 50–55%) and S. dysenteriae (n = 4, 25%). In S. sonnei (n = 10)
intI-1 was found to occur more  frequently (90%) than intI-2
(10%) whereas in S. boydii (n = 11) the opposite was found to be
true as intI-2 was more  frequently observed (45%) than intI-1
(9%).
In Brazil, class 2 integrons were more  prevalent in S. ﬂexneri
and S. sonnei than class 1 integrons.42,43 It is of importance that
class 3 integrons were not detected in Brazil, Chile, Costa Rica
and Peru.
In Brazil, the sulfonamide resistant gene (sul1) was
detected in 2 of the 62 (3%) multidrug resistant-Shigella that
were also positive for presence of class 1 integrons 41 and
results along similar lines were also reported from Peru. Curi-
ously, it was found that sul1, in bacterial strains harboring
typical class 1 integrons, is associated with resistance to
trimethoprim sulfamethoxazole.50,51 A study conducted by
Reyes et al.52 reported that in case of isolates identiﬁed from
Chilean hospitals, Class 1 integrons were found to be most
prevalent in enterobacterial isolates (62 out of 191 strains,
62.4%) including the Shigella spp. They further speciﬁed that
among Shigella spp., class 2 integrons were found only in ﬁve
strains. Interestingly, One of these isolates was also found to
contain a class 1 integron. The authors went on to characterize
the variable regions of 13 class 1 integrons and identiﬁed four
distinct types: type 1 carrying ant(3′′)I, type 2 carrying ant(2′′)I
and ant(3′′)I, type 3 carrying aac(6′)Ib and ant(3′′)I, and type 4
was an empty integron.
The class 1 integrons differ from the class 2 in their capac-
ity to integrate and excise gene cassettes, and also in terms
of the presence of sul1 gene in the 3′ conserved segment
(3′CS).42 In Brazil, Costa Rica and Peru the gene cassette sul2 is
more  frequently detected in Shigella isolates that are resistant
to sulfonamides, which suggests that sulfonamide-resistant
 i c r o
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phenotype could be explained by the detection of sul2 genes
independent of the integron class detected; sul3 was negative
in all isolates.42,47
On the basis of the model of a culture-based methodol-
ogy without antibiotic selection, it was suggested that the
sul1 gene cassette is a genetic determinant associated with
urbanization.53 In a study developed at Tierra de Fuego, the
Patagonian Island of Argentina, antibiotic resistant genes
such as sul 1 and qacE1/qacED1,  both of which are embed-
ded in class 1 integrons, exhibited varying ecological and
molecular behavior in environmental samples. While the
sul1 gene frequency was clearly related to urbanization, the
qacE1/qacED1 gene demonstrated an adaptive role to several
habitats indicating that its presence has been widespread for
a considerable time and emphasizing its role in terms of a
large variety of genomes, habitats, and possibly different types
of stressors. Gene cassette sul1 exhibited a high frequency
in urban sites, which could possibly be the consequence of
the genetic ﬂow of clinical sul1 alleles from the hospital
toward the open environment, where they are absorbed by non
clinical strains and, in all likelihood, maintained by the pres-
ence of contaminants that are co-selected for sulfonamide
resistance.53
The high frequency of sulfonamide (encoded by sul2) and
trimethoprim resistance is possibly a direct result of the recur-
rent use of trimethoprim sulfamethoxazole as a treatment
modality for shigellosis.42 The generalized resistance pro-
ﬁle of Shigella spp. toward ampicillin (40–100% of isolates),
and trimethoprim–sulfamethoxazole (27–100% of isolates)
conﬁrms that these antibiotics are ineffective for empirical
therapy.42,47,54,55 Most of the ampicillin-resistant strains are
associated with the presence of an OXA-type -lactamase.
This gene cassette was found to occur with a higher frequency
as compared to the CARB-like and TEM-1 -lactamases, which
were also detected in some of the isolates.24,42,46,48
The chloramphenicol resistance gene catA1, which
encodes for chloramphenicol o-acetyl-transferase, was
detected in 100% of the chloramphenicol-resistant strains
in Brazil and Chile and in about 86% of similarly resistant
strains in Peru. In addition, in all the three countries, tet(B)
was the dominant tetracycline-resistant gene detected, which
explains the high level of chloramphenicol and tetracycline
resistance proﬁle that had been observed.24,42,46
Some studies have hypothesized that insertion of the class
1 integrons within the Shigella resistance locus (SRL) may be
able to explain the chloramphenicol and tetracycline resis-
tance observed in strains containing class 1 integron. It is also
a distinct possibility that the insertion-sequence regions may
be deleted or inserted independently at hot spots, such as orfB
of IS600, as is the case for integration of the class 1 integrons
within the transposons of the Tn3 family. Conserved orga-
nization of the class 1 integron in unrelated Shigella strains
might be linked to the insertion and stabilization of these
elements within mobile genetic superstructures such as SRL
and PAI; such phenomenon may be dependent upon mecha-
nisms such as the expression of the distal gene cassettes and
hence merits an in-depth exploration.36,44 This observation
could aid in explaining the phenotypes of chloramphenicol
and tetracycline-resistance in Shigella harboring class 1 inte-
grons in the speciﬁc case of Latin America. b i o l o g y 4 7 (2 0 1 6) 800–806
Conclusion
Increased prevalence of antibiotic resistance is a major threat
against controlling shigellosis. In Latin America, a few studies
have proposed that antibiotic resistance genes together with
integrons make up the molecular mechanism that has the
potential to be involved in transmission of multidrug resis-
tance genes in this pathogen. Studies conducted in Brazil,
Bolivia, Chile, Costa Rica and Peru have shown that class 1
and class 2 integrons are present among multidrug resistant
Shigella isolates harboring the OXA-type -lactamase, and less
frequently, the CARB-like and TEM-1 -lactamases. In one of
these studies class 1 integrons were characterized and certain
types of integrons were described comprehensively.
The observed antibiotic resistance proﬁle conﬁrmed that
ampicillin and trimethoprim–sulfamethoxazole are ineffec-
tive for therapeutic purposes against Shigella. More  compre-
hensive and in-depth information about antibiotic resistance
mechanisms in this pathogen is needed in order to develop
suitably effective interventional strategies. To this purpose,
acquiring regional and local antimicrobial resistance proﬁles
for all Shigella patients should be considered for inclusion as a
part of the public health strategy.
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